Loading component...
Loading component...
Publications
Read their latest work
Article
Building a long-range GLP-1 forecast: When could commercial health plans see a plateau?
11 September 2025 - by John Rogers, Liam Kussman, Brian Anderson, Jeremy Sarich, Andrew Marshall
GLP-1 drugs: We provide a framework for building a long-range forecast to help employers understand how trends may change over time.
Article
Understanding the cost dynamics of antidiabetic medications: A trend analysis (2016-2024)
19 December 2024 - by John Rogers, Barbara Dewey
Using eight years’ worth of data, we provide some historical trends for antidiabetic medications to help plan sponsors better understand cost drivers.
Video
Midnight approaches: Reactions to Part D reforms
20 March 2024 - by Jeremy Sarich, John Rogers, Les Kartchner, Michelle (Klein) Robb
As midnight on June 3 approaches, many plans face considerable uncertainties relating to the Inflation Reduction Act’s benefit redesign, Medicare Prescription Payment Plan, and changes from the Advance Notice.
Article
Best practices: Is your point solution on point?
25 April 2023 - by Kylie Young, John Rogers, Alex Zuckerman
We provide decision-making guidance for health plan sponsors looking to implement point solutions to reduce overall healthcare costs, increase healthcare access, and improve health outcomes.
Video
Webinar: How do you look? Positioning your plan in Medicare Plan Finder
10 November 2021 - by Todd Wanta, Merry Beth Ward, John Rogers, Deana Bell
Article
How might COVID-19 impact 2021 supplemental benefits
10 April 2020 - by John Rogers, Annie Man, Kyle Hutmaker
While no one knows what will happen with COVID-19 in 2021, in the absence of a vaccine or other curative treatment, Medicare Advantage plans may be advised to consider possible impacts of the disease well into the future.
